SG Americas Securities LLC Has $97.74 Million Stock Holdings in Cencora, Inc. $COR

SG Americas Securities LLC decreased its position in shares of Cencora, Inc. (NYSE:COR) by 2.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 311,140 shares of the company’s stock after selling 8,406 shares during the period. SG Americas Securities LLC owned approximately 0.16% of Cencora worth $97,742,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. AustralianSuper Pty Ltd bought a new stake in shares of Cencora in the third quarter valued at approximately $26,191,000. Lansforsakringar Fondforvaltning AB publ increased its stake in Cencora by 5.4% during the 3rd quarter. Lansforsakringar Fondforvaltning AB publ now owns 60,254 shares of the company’s stock worth $18,831,000 after acquiring an additional 3,073 shares during the period. Chilton Investment Co. Inc. acquired a new position in Cencora in the 3rd quarter valued at $459,000. Nordea Investment Management AB raised its holdings in Cencora by 3.8% in the 4th quarter. Nordea Investment Management AB now owns 1,256,356 shares of the company’s stock valued at $426,715,000 after acquiring an additional 45,712 shares in the last quarter. Finally, Assetmark Inc. lifted its position in shares of Cencora by 57.0% during the 4th quarter. Assetmark Inc. now owns 67,281 shares of the company’s stock valued at $22,724,000 after acquiring an additional 24,431 shares during the period. Institutional investors and hedge funds own 97.52% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on COR shares. UBS Group increased their target price on Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Evercore set a $360.00 price objective on shares of Cencora in a research report on Wednesday, April 8th. Weiss Ratings downgraded shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, May 22nd. Wells Fargo & Company decreased their price target on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research note on Monday, May 11th. Finally, Leerink Partners reiterated an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Cencora has a consensus rating of “Moderate Buy” and an average target price of $374.00.

Cencora Price Performance

Shares of COR opened at $271.99 on Monday. The company has a market capitalization of $52.92 billion, a price-to-earnings ratio of 20.86, a price-to-earnings-growth ratio of 1.47 and a beta of 0.59. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The business has a 50-day moving average of $284.59 and a 200-day moving average of $324.10.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. During the same period in the prior year, the company posted $4.42 earnings per share. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities research analysts anticipate that Cencora, Inc. will post 17.79 earnings per share for the current year.

Cencora Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were paid a $0.60 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.9%. Cencora’s payout ratio is 18.40%.

Cencora declared that its Board of Directors has initiated a share repurchase program on Thursday, May 21st that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to purchase up to 3.9% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s leadership believes its shares are undervalued.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.